
|Articles|July 31, 2008
Obagi Medical Products presents promising in vitro data for topical C serums
Chicago - Obagi Medical Products announces in vitro data showing that Obagi-C Rx Serum provided more than 10 times the absorption of vitamin C than the leading competitive product, Skinceuticals, according to Marketwatch.com.
Advertisement
Chicago
- Obagi Medical Products announces
in vitro
data showing that Obagi-C Rx Serum provided more than 10 times the absorption of vitamin C than the leading competitive product, according to Marketwatch.com.
In addition, the Obagi Professional-C Serum had a five-fold greater absorption of vitamin C than the leading competitive product, and both Obagi products were proven to have a greater stability than the leading competitor.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
CSU With Biochemical C1 Inhibitor Deficiency: Case Report Raises Diagnostic Questions
2
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
3
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
4
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
5











